Atlas Trials

Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases

Clinical trial NCT02862132 · COMPLETED

Trial details

NCT number
NCT02862132
Sponsor
Shaare Zedek Medical Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Crohn's DiseaseUlcerative ColitisInflammatory Bowel Disease
Start date
2017-01-01
Primary completion
2022-01-01
Enrollment
142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.